Cronos Group Inc (NASDAQ:CRON) saw some unusual options trading activity on Thursday. Stock traders bought 58,950 put options on the company. This is an increase of approximately 2,569% compared to the typical daily volume of 2,209 put options.

CRON traded up $0.27 during trading on Friday, reaching $10.38. 20,672,012 shares of the company’s stock were exchanged, compared to its average volume of 31,901,536. Cronos Group has a fifty-two week low of $1.50 and a fifty-two week high of $13.39. The company has a debt-to-equity ratio of 0.02, a current ratio of 52.98 and a quick ratio of 44.71. The company has a market capitalization of $1.99 billion and a P/E ratio of 1,127.00.

Separately, Canaccord Genuity raised shares of Cronos Group from a “sell” rating to a “hold” rating in a research report on Wednesday, August 15th.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. ETF Managers Group LLC acquired a new stake in shares of Cronos Group in the 1st quarter valued at $13,583,000. JW Asset Management LLC acquired a new stake in shares of Cronos Group in the 1st quarter valued at $7,480,000. Commonwealth Equity Services LLC boosted its stake in shares of Cronos Group by 77.0% in the 2nd quarter. Commonwealth Equity Services LLC now owns 77,445 shares of the company’s stock valued at $505,000 after purchasing an additional 33,687 shares in the last quarter. Lourd Capital LLC acquired a new stake in shares of Cronos Group in the 2nd quarter valued at $379,000. Finally, Fiera Capital Corp bought a new position in shares of Cronos Group in the first quarter valued at about $336,000. Hedge funds and other institutional investors own 9.47% of the company’s stock.

About Cronos Group

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations (?MMPR?). The firm typically invests in companies based in Canada.

Further Reading: Should you buy a closed-end mutual fund?

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.